Company News

Our latest Press Releases

Pharmadrug Advances Opthalmology Program with Final…

May 3, 2022

Learn more >

PharmaDrug Advances Oncology Program with Filing…

April 19, 2022

Learn more >

PharmaDrug Advances DMT-Analogue Program for Glaucoma…

April 7, 2022

Learn more >

Pharmadrug Advances PD-001, Its Patented, Improved…

April 1, 2022

Learn more >

PharmaDrug Announces Interim Positive Findings for…

March 9, 2022

Learn more >

PharmaDrug Receives Positive Results for DMT-Analogue…

February 23, 2022

Learn more >

PharmaDrug Announces Filing of US Provisional…

February 1, 2022

Learn more >

PharmaDrug Announces Initiation of Manufacturing of…

January 26, 2022

Learn more >

PharmaDrug to Present at Wall Street…

January 24, 2022

Learn more >

PharmaDrug Engages Octagon Media and Affiliated…

January 20, 2022

Learn more >

PharmaDrug Announces Resignation of Director

January 13, 2022

Learn more >

PharmaDrug Announces Addition of Dr. Cindy…

December 13, 2021

Learn more >

Pharmadrug Announces Successful Completion of Pre-IND…

November 30, 2021

Learn more >

PharmaDrug Provides Research Results and Initiates…

November 18, 2021

Learn more >

Study Results in the Prestigious Journal…

November 9, 2021

Learn more >

PharmaDrug Advances Psychedelics Program with Analogue…

November 5, 2021

Learn more >

PharmaDrug Expands Product Offering to Prepare…

November 1, 2021

Learn more >

PharmaDrug Commences Trading on the OTCQB…

October 20, 2021

Learn more >

PharmaDrug Announces Positive Research Results for…

October 15, 2021

Learn more >

PharmaDrug Announces pre-IND Meeting Request Granted…

September 28, 2021

Learn more >

PharmaDrug Announces Clinical Research Collaboration with…

August 25, 2021

Learn more >

PharmaDrug Forms Research Collaboration with Terasaki…

August 5, 2021

Learn more >

PharmaDrug Announces Stock Ticker Symbol Change…

July 30, 2021

Learn more >

Pharmadrug Announces Positive Research Results of…

July 28, 2021

Learn more >

Get The Latest PharmaDrug
Developments

Loading